Skip to textbook content
Doctor’s PassportTextbook
QuestionsFlashcardsBriefsDashboardAccount
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Obstetrics and gynaecology indexChapter sections
OverviewAetiologyPathophysiologyClinical features and red flagsInvestigationsDifferential diagnosisManagementComplicationsMonitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook13 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Multiple pregnancy and twin complications

Obstetrics and gynaecology · UK scope · Sources checked 7 Sept 2026 · Clinical review pending

RapidFull
!
Monochorionic twins with discordant fluid or deterioration

A marked difference in sac fluid, a missing donor bladder, abnormal Dopplers, hydrops or acute maternal distension may indicate a shared-placenta complication requiring fetal therapy assessment.

Action: Contact the tertiary fetal medicine service promptly, document gestation and consistent fetal labels, and provide each sac’s fluid, bladder, growth and Doppler findings; urgent maternal or fetal compromise requires immediate maternity assessment.

Overview

Use chorionicity and amnionicity to organise multiple-pregnancy care, recognise shared-placenta complications and plan surveillance, preterm prevention and birth for each fetus.

Multiple pregnancy changes maternal physiology, fetal surveillance and practical preparation for birth. The first ultrasound should establish gestation, chorionicity and amnionicity, using placental appearance and the dividing membrane rather than a label such as identical twins. Date from the larger early crown-rump length to avoid basing gestation on an already growth-restricted fetus. If chorionicity remains uncertain after expert review, manage as monochorionic until clarified. Record fetal position labels in a way that remains usable at subsequent scans and during any procedure.

Dichorionic fetuses have separate placental circulations, whereas monochorionic fetuses share a placenta that often contains vascular connections. Unequal transfer across these connections can produce twin-to-twin transfusion syndrome, in which the donor develops reduced urine output and low fluid while the recipient develops excess fluid and cardiovascular strain. Twin anaemia-polycythaemia sequence reflects slower red-cell imbalance and may occur without the dramatic oligohydramnios-polyhydramnios pattern. Selective growth restriction is another shared-placenta problem and can coexist with either syndrome; these diagnoses should not be conflated.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
Obstetrics and gynaecologyOriginal SBA

Gestation-specific transfusion thresholds

At 21 weeks, monochorionic diamniotic twins have donor DVP 1.5 cm and recipient DVP 11 cm. What is the appropriate next action?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Obstetrics and gynaecology topics →
Sources and review status5 sources · checked 7 Sept 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.

  • NICE NG137 twin and triplet recommendations
  • NICE NG137 complete 2024 text in NCBI Bookshelf
  • RCOG monochorionic twin guidance 2024 partial update
  • ISUOG ultrasound in twin pregnancy 2025
  • NICE NG133 pre-eclampsia prevention

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom

Surveillance follows the risks of the placental arrangement. Monochorionic twin or triplet pregnancy needs scans at no more than 14-day intervals from 16 weeks, assessing fluid in each sac and evidence of growth or transfusion complications. Dichorionic twin growth monitoring begins from 24 weeks and should not be spaced more than 28 days apart. Increase monitoring if growth discordance or smallness emerges. The scan is not simply a combined weight check: report each fetus’s anatomy, growth, fluid, bladder and appropriate Dopplers and recognise when a finding needs specialist interpretation.

Maternal care includes anaemia surveillance, blood pressure and proteinuria assessment, thrombosis risk and a discussion of preterm labour symptoms. NICE’s 2024 update recommends a single cervical-length scan between 16 and 20 weeks and vaginal progesterone for a cervix measuring 25 mm or less; routine treatment of every twin pregnancy is not the recommendation. Prepare families for the possibility of neonatal admission, feeding difficulties and practical support needs, without presenting prematurity as inevitable. Birth timing differs by chorionicity and complications, and vaginal birth may be appropriate for selected twins when the first twin is cephalic.

Key points

  • Determine chorionicity and amnionicity early; they guide risk and surveillance more directly than whether twins are genetically identical.
  • Use consistent fetal labels throughout every scan and report so measurements and interventions are attributed to the same fetus.
  • Monochorionic pregnancies need ultrasound surveillance every 14 days from 16 weeks for transfusion-related and growth complications.
  • Calculate weight discordance as the difference between larger and smaller estimated weight divided by the larger weight, multiplied by 100.
  • Increase surveillance for at least 20% discordance or any fetus below the tenth centile; at least 25% plus a fetus below the tenth warrants tertiary review.
  • For uncomplicated twins, offer planned birth at 37 weeks for DCDA, 36 weeks for MCDA and 32+0 to 33+6 weeks for MCMA.

Aetiology

01

Two fertilisations or embryonic division

Dizygotic twins arise from separate fertilisations, while monozygotic twinning follows division of one conceptus; the timing of division influences placental and amniotic arrangements.

02

Placental sharing

Monochorionic vascular connections and unequal placental allocation create risks of transfusion imbalance and selective restriction beyond the prematurity risks shared by multiple pregnancies.

Pathophysiology

  1. 1
    Unequal placental blood exchange

    Unbalanced net flow across placental vessels can deplete the donor and overload the recipient, producing different urine outputs, sac volumes and cardiovascular effects.

  2. 2
    Slow red-cell transfer

    Small vascular communications can produce progressive donor anaemia and recipient polycythaemia without a marked fluid imbalance, explaining the different TAPS screening pattern.

  3. 3
    Uterine and maternal load

    More than one fetus increases uterine distension and maternal metabolic demand, contributing to preterm labour, anaemia, hypertensive complications and postpartum uterine atony.

Clinical features and red flags

Chorionicity at diagnosis

A lambda sign supports dichorionicity and a T-sign supports monochorionicity; seek experienced review if the membrane or placental arrangement is unclear.

TTTS fluid pattern

Donor oligohydramnios and recipient polyhydramnios in a monochorionic pair is the characteristic pattern, with gestation-specific recipient depth thresholds for referral.

Selective growth restriction

A substantial estimated weight difference together with a small fetus suggests placental inequality requiring closer Doppler-based surveillance and possible tertiary assessment.

Anaemia-polycythaemia sequence

Discordant middle cerebral artery velocities can reveal red-cell imbalance even without striking fluid discordance, particularly after laser treatment or with selective restriction.

Red flags requiring action

  • A monochorionic donor sac DVP below 2 cm with recipient DVP above 8 cm before 20+0 weeks or above 10 cm from 20+0 weeks requires referral for suspected TTTS.
  • Rapid painful abdominal enlargement, breathlessness, reduced movements or preterm labour symptoms in a multiple pregnancy warrants immediate maternity review.
  • Single fetal death in a monochorionic pregnancy needs urgent specialist assessment of the survivor because shared vessels create additional neurological and circulatory risks.

Investigations

  1. 01
    Early ultrasound and persistent fetal labellingFirst step
    Why
    Establish gestation, chorionicity, amnionicity and identity for repeated assessments.
    Interpretation and limitations
    Use membrane and placental features and obtain expert help for uncertainty; inconsistent labels can create false growth trends or target the wrong fetus.
  2. 02
    Serial growth and discordance calculation
    Why
    Identify interval restriction and clinically significant differences between fetuses.
    Interpretation and limitations
    Divide the weight difference by the larger estimated weight; at least 20% discordance or any weight below the tenth centile calls for increased monitoring.
  3. 03
    DVP and bladder assessment in each sac
    Why
    Screen monochorionic pregnancies for the TTTS oligohydramnios-polyhydramnios sequence.
    Interpretation and limitations
    NICE referral thresholds are donor DVP below 2 cm and recipient above 8 cm before 20 weeks or above 10 cm from 20 weeks.
  4. 04
    Umbilical and selected MCA Dopplers
    Why
    Evaluate placental resistance and investigate fetal anaemia or polycythaemia.
    Interpretation and limitations
    MCA peak systolic velocity addresses anaemia, while umbilical flow addresses placental resistance; fetal medicine determines additional venous assessment and therapy.

Differential diagnosis

01

Growth discordance without TTTS

Unequal placental sharing or constitutional differences can produce different weights without the donor-recipient fluid pattern; assess growth restriction rather than assuming transfusion.

02

Singleton-type fluid disorder in one twin

A structural anomaly or another cause of altered fluid production can affect one sac, so anatomy and chorionicity must support the transfusion diagnosis.

03

TAPS versus other fetal anaemia

Maternal red-cell antibodies, infection or fetomaternal haemorrhage can also raise fetal MCA velocity; interpret the paired findings and exposure history through fetal medicine.

Management

01Structured antenatal careBuild a chorionicity-specific care planFirst stepA twin or triplet pregnancy has been confirmed and requires an organised surveillance schedule.+
  1. 1Assign a specialist maternity team, establish chorionicity and amnionicity and keep consistent fetal labels visible in all reports.
  2. 2Book scans appropriate to chorionicity, assess maternal anaemia and pre-eclampsia risks, and discuss cervical-length screening and preterm symptoms.
  3. 3Provide a provisional birth plan early enough for neonatal counselling, practical preparation and informed choices about route and place.
02Complication detectedRefer a growth or transfusion concern promptlyA scan shows discordant fluid, significant growth inequality, anaemia features or abnormal Dopplers.+
  1. 1Send the tertiary team gestation, chorionicity, each fetal label, DVP, bladder visibility, estimated weights and all Doppler findings.

Complications

01

Prematurity and neonatal needs

Spontaneous preterm labour and medically indicated early birth increase neonatal respiratory, feeding and temperature problems, requiring coordinated counselling and suitable neonatal resources.

02

Shared-circulation fetal injury

TTTS, TAPS, selective restriction or co-twin death can threaten both fetuses through linked placental circulations, sometimes requiring invasive fetal treatment or earlier delivery.

03

Maternal morbidity

Anaemia, pre-eclampsia, operative delivery and postpartum haemorrhage are more frequent concerns, so maternal surveillance and birth preparation must accompany the fetal scan schedule.

Monitoring and follow-up

  • Audit that monochorionic scan intervals remain no longer than 14 days from 16 weeks and that missed appointments trigger active rescheduling.
  • Track each fetus separately for growth, sac fluid, bladder and Dopplers, preserving labels through referrals and intervention.
  • Review maternal blood pressure, proteinuria, haemoglobin and symptoms alongside fetal findings rather than focusing solely on twin measurements.
  • Revise timing and place of birth after new complications, and communicate fetal identities and expected neonatal needs to the delivery team.

Special situations

Shared placenta determines risk

Genetically identical twins can be dichorionic, so zygosity is not a reliable shortcut for deciding the surveillance pathway.

Different transfusion syndromes

TTTS commonly has a fluid imbalance, while TAPS can present through discordant MCA velocities without the same fluid pattern; each needs its own diagnostic assessment.

After a co-twin death

A surviving monochorionic fetus can suffer acute haemodynamic injury through placental connections, making prompt specialist counselling and follow-up essential even if the heartbeat persists.

Preterm prevention changed

The 2024 NICE update supports cervical-length screening and progesterone for a short cervix in multiples, replacing older teaching that dismissed this selected-group intervention.

Common pitfalls

  1. 01

    Calling twins identical and assuming that establishes chorionicity or the necessary scan frequency.

  2. 02

    Calculating discordance using the smaller fetus as denominator and thereby overstating the percentage difference.

  3. 03

    Using a recipient DVP just above 8 cm after 20 weeks as though it meets the NICE TTTS referral fluid threshold.

  4. 04

    Reusing the singleton birth timetable for twins or continuing an uncomplicated timetable after a new fetal complication.

05
Cervical length and maternal laboratory surveillance
Why
Identify a short cervix and maternal anaemia or hypertensive disease.
Interpretation and limitations
Offer cervical measurement at 16–20 weeks; an additional full blood count at 20–24 weeks supplements booking and 28-week testing in multiple pregnancy.
2
For a monochorionic DVP difference of at least 4 cm, increase monitoring to at least weekly with umbilical Dopplers; an abnormal single-sac value without the complete TTTS pattern still needs named specialist review.
  • 3Increase monitoring to at least weekly with umbilical Dopplers when discordance reaches 20% or any fetus is below the tenth centile.
  • 4Refer at least 25% discordance plus a fetus below the tenth centile, or suspected TTTS/TAPS, for specialist counselling about surveillance, laser or other intervention.
    • 03Planned birthMatch timing and route to the pregnancyA multiple pregnancy approaches the recommended gestation or an earlier complication changes risk.+
    1. 1Offer uncomplicated DCDA twins birth at 37 weeks, MCDA at 36 weeks and MCMA at 32+0–33+6 weeks after appropriate preparation.
    2. 2For uncomplicated trichorionic or dichorionic triamniotic triplets offer 35-week planned birth; individualise shared-amnion or other complicated arrangements.
    3. 3Discuss vaginal versus caesarean birth for eligible twins after 32 weeks, considering first-twin presentation, discordance and contraindications; MCMA twins and triplets usually require caesarean planning.
    Key medicines and prescribing safety2 treatments · regimens, roles and cautions+
    NICE-supported prevention of preterm birth in the selected short-cervix group, including an incidental finding at 20–24 weeks.

    Vaginal progesterone for a short cervix

    Offer 200 mg vaginal capsules once daily at bedtime when a twin or triplet pregnancy has cervical length 25 mm or less; continue until 34 weeks or earlier birth.

    This use in twins and triplets is off-label; discuss the indication and preparation, and do not apply it universally to all multiple pregnancies.

    Prevents pre-eclampsia in eligible pregnancies; multiple pregnancy counts as one moderate-risk factor.

    Aspirin for qualifying pre-eclampsia risk

    Prescribe 75–150 mg orally daily from 12 weeks until birth when NICE risk assessment identifies one high-risk or more than one moderate-risk factor.

    Twins alone do not satisfy the multiple-moderate-factor rule; document additional risk, allergy and relevant bleeding concerns.